JPRN-jRCT2080222663未知2 期
Safety of BK1301 in healthy adults
The Research Foundation for Microbial Diseases of Osaka University0 个研究点目标入组 20 人开始时间: 2014年11月21日最近更新:
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Healthy adults
排除标准
- •History of diphtheria, tetanus, pertussis injection
- •Individuals who received vaccines containing diphtheria, tetanus, or pertussis within 5 years
研究者
相似试验
未知
2 期
Phase II study of BK1304 in healthy adultsPrevention of influenzaJPRN-jRCT2080223352The Research Foundation For Microbial Diseases Of Osaka University600
已完成
3 期
Phase III study of BK1304 in healthy adults and adolescentsPrevention of influenzaJPRN-jRCT2080224074The Research Foundation for Microbial Diseases of Osaka University1,500
已完成
2 期
Phase 2 study of BK1304 in healthy childrePrevention of influenzaJPRN-jRCT2031200156Fuji Hideyuki120
已完成
1 期
SK-5307 P I single-dose study.JPRN-jRCT2071220045Kenji Asano38
进行中（未招募）
1 期
aSarcopenia including sarcopenic obesityMedDRA version: 20.1Level: PTClassification code 10063024Term: SarcopeniaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2017-003932-35-BEBiophytis S.A.231